Launched in 1993, the landmark Women’s Health Initiative Studies (WHI) were designed to examine the effects of oestrogen and progestin and oestrogen alone in post-menopausal women. While the study’s findings have been consistently disproven, has clinical practice cottoned on to the benefits of hormone replacement therapy yet?
Infertility is estimated to affect between 8% and 12% of reproductive-aged couples worldwide. In some regions of the world such as South and Central Asia, the Middle East, sub-Saharan and North Africa as well as Eastern Europe, the rates of infertility are much higher, reaching ∼30%.
We chat to Prof David Kendler, director of the Osteoporosis Programme at Providence Health Care in Vancouver (Canada) and Dr Sue Brown, council member of the National Osteoporosis Foundation of South Africa (NOFSA) about glucocorticoid-induced osteoporosis (GIOP).
The choice of biological drug for the treatment of rheumatoid arthritis is a highly significant one and should be informed by a clear understanding of the patient’s disease profile.
The aetiology of vaginitis can be from infections of Candidiasis (thrush), Trichomoniasis, or bacterial vaginosis and it is important to distinguish them clearly.
Recent fragility fracture is a powerful predictor of imminent risk of fracture.
At the recent National Osteoporosis Foundation of South Africa (NOFSA) Congress, held from 16 – 18 March in Cape Town, Prof Brent Tipping of the University of the Witwatersrand and Dr Zane Stevens of Stellenbosch University shared their valuable real-world experiences.